How Much Upside is Left in MiMedx Wall Street Analysts Think 37.12
MDXG Stock | USD 6.72 0.18 2.61% |
Roughly 62% of MiMedx's investor base is looking to short. The analysis of the overall investor sentiment regarding MiMedx Group suggests that many traders are alarmed. The current market sentiment, together with MiMedx's historical and current headlines, can help investors time the market. In addition, many technical investors use MiMedx Group stock news signals to limit their universe of possible portfolio assets.
The mean of analysts price targets for MiMedx points to a 37.1 percent upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Read at zacks.com
![]() |
MiMedx Fundamental Analysis
We analyze MiMedx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MiMedx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MiMedx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
MiMedx is currently under evaluation in target price category among its peers.
MiMedx Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MiMedx stock to make a market-neutral strategy. Peer analysis of MiMedx could also be used in its relative valuation, which is a method of valuing MiMedx by comparing valuation metrics with similar companies.
Peers
MiMedx Related Equities
HOWL | Werewolf Therapeutics | 2.78 | ||||
ZNTL | Zentalis Pharmaceuticals | 2.48 | ||||
GPCR | Structure Therapeutics | 2.07 | ||||
GLUE | Monte Rosa | 1.00 | ||||
KROS | Keros Therapeutics | 0.85 | ||||
CCCC | C4 Therapeutics | 0.74 | ||||
CGEM | Cullinan Oncology | 0.25 | ||||
INZY | Inozyme Pharma | 0.25 | ||||
STOK | Stoke Therapeutics | 0.21 | ||||
PTGX | Protagonist Therapeutics | 0.20 | ||||
DAWN | Day One | 0.32 | ||||
ERAS | Erasca | 0.82 | ||||
IKNA | Ikena Oncology | 0.87 | ||||
NVCT | Nuvectis Pharma | 1.00 | ||||
DSGN | Design Therapeutics | 1.55 | ||||
CNTA | Centessa Pharmaceuticals | 1.56 | ||||
IPSC | Century Therapeutics | 1.75 | ||||
MLYS | Mineralys Therapeutics, | 2.04 | ||||
EWTX | Edgewise Therapeutics | 3.91 | ||||
CVKD | Cadrenal Therapeutics, | 4.27 | ||||
SNDX | Syndax Pharmaceuticals | 8.88 |
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Transaction History View history of all your transactions and understand their impact on performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |